Consolidated Cash Flows
For the years ended December 31 ($Cdn thousands) |
Note | 2012 | (Recast – note 6) 2011 |
---|---|---|---|
See accompanying notes to consolidated financial statements. | |||
Operating activities | |||
Net earnings | $264,583 | $449,844 | |
Adjustments for: | |||
Depreciation and amortization | 293,429 | 274,663 | |
Deferred charges | (2,910) | (7,869) | |
Unrealized losses (gains) on derivatives | (22,057) | 60,558 | |
Share-based compensation | 27 | 17,550 | 19,492 |
Loss (gain) on sale of assets | (1,660) | 7,602 | |
Finance costs | 22 | 80,349 | 73,668 |
Finance income | (20,745) | (24,547) | |
Share of loss from equity-accounted investees | 13 | 6,005 | 7,233 |
Impairment charge on non-producing property | 10 | 168,000 | – |
Other income | 23 | (4,796) | (4,920) |
Income tax expense (recovery) | 24 | (46,376) | 11,755 |
Interest received | 21,964 | 23,718 | |
Income taxes paid | (54,475) | (60,744) | |
Income taxes refunded | 18,569 | 30,128 | |
Other operating items | 26 | (73,518) | (115,719) |
Net cash provided by operations | 643,912 | 744,862 | |
Investing activities | |||
Additions to property, plant and equipment | 10 | (733,648) | (647,137) |
Acquisitions | 37 | (576,408) | – |
Decrease in short-term investments | 754,434 | 79,228 | |
Decrease (increase) in long-term receivables, investments and other | (26,294) | 39,890 | |
Proceeds from sale of property, plant and equipment | 3,315 | 62 | |
Net cash used in investing | (578,601) | (527,957) | |
Financing activities | |||
Increase in debt | 527,606 | 12,105 | |
Decrease in debt | (35,629) | (14,713) | |
Interest paid | (53,956) | (60,533) | |
Proceeds from issuance of shares, stock option plan | 7,033 | 7,339 | |
Dividends paid | (158,066) | (146,017) | |
Net cash provided by (used in) financing | 286,988 | 201,819 | |
Increase in cash during the period | 352,299 | 15,086 | |
Exchange rate changes on foreign currency cash balances | (559) | 7,618 | |
Cash and cash equivalents at beginning of period | 398,084 | 375,380 | |
Cash and cash equivalents at end of period | $749,824 | $398,084 | |
Cash and cash equivalents is comprised of: | |||
Cash | $204,694 | $48,353 | |
Cash equivalents | 545,130 | 349,731 | |
$749,824 | $398,084 |